A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
Amgen
Faculdade de Ciências Médicas de Minas Gerais
OncoNano Medicine, Inc.
University of Texas Southwestern Medical Center
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Rabin Medical Center
Beijing Chao Yang Hospital